Drug Safety :: AARP praises drug safety, generic drug market access provisions of FDA Bill
AARP hailed the Senate passage of two provisions that would improve drug safety and improve generic drug market access. The provisions were part of a Food and Drug Administration (FDA) bill that reauthorizes the prescription drug user fee programs at FDA, known as the Prescription Drug User Fee Amendments of 2007 ? or, PDUFA ? (S. 1082).